EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, invites you to visit booth #2841 at INTERPHEX 2014
in New York City to learn about the company's portfolio of solutions for the entire biopharmaceutical process. A complete range of upstream and downstream technologies helps the biopharmaceutical industry make, purify, formulate and assure the quality and safety of drug production. Single and multi-use solutions, including customizable hardware, allow manufacturers to develop processes to meet their specific requirements. The end result is improved efficiency, productivity and accelerated time to market.
Products on display for the first time at INTERPHEX include
Cellvento Cell Culture Media
EMD Millipore offers a comprehensive chemicals portfolio, including high-quality, chemically defined cell culture media manufactured under cGMP conditions. The Cellvento CHO media platform provides non-animal origin media formulations for batch and fed-batch mode operations, delivering robust cell growth and consistent high performance.
Clarisolve Depth Filters
Clarisolve depth filters are the first primary clarification offering with a gradient density structure specifically designed to the particle size distributions of pretreated feed streams. The filters allow biopharmaceutical manufacturers to move directly from primary clarification to downstream sterile filtration without the need for centrifugation or a secondary clarification stage, reducing overall footprint and improving process economics. EMD Millipore has also developed a cationic pDADMAC (poly diallyldimenthyl ammonium chloride) flocculation reagent which, in combination with Clarisolve depth filters, provides an effective solution for harvesting high cell density cultures and can be easily incorporated into current clarification platforms.
Pellicon 3 Cassettes with Ultracel Membrane with New D Screen for High Viscosity Applications
These advanced, high-performance cassettes are ideal for today's higher-titer therapeutic antibodies, as well as demanding filtration processes that require higher operating pressures, temperatures, concentrations and caustic cleaning regimes. With the new high viscosity screen, biopharmaceutical producers can reach higher concentration for Mabs, rec IgG and recombinant protein.
DRYPOUR Packaging Systems
The DRYPOUR packaging system minimizes the caking of hygroscopic salts used in pharmaceutical manufacturing during transport and storage. The system, which uses desiccant bags integrated into a polyethylene liner, helps improve operational efficiency by reducing the need to manually break up heavily caked raw materials.
EMD Millipore will also be presenting at INTERPHEX
Design Considerations for Formulation and Filling
Presented by Susan Walker
Market Development Manager - Final Fill, EMD Millipore
Wednesday, March 19, 2:45 p.m. - 3:45 p.m.
Integrated Single-Use Purification Technologies Enabling Continuous MAb Processing
Presented by Michael W. Phillips, Ph.D.
Research Fellow, Processing Technologies, EMD Millipore
Wednesday, March 19, 3:30 p.m. - 3:55 p.m.
BPI Innovation Theatre
To schedule a meeting with EMD Millipore in advance, please contact
Feinstein Kean Healthcare
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2012 revenues of €2.6B. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
SOURCE: EMD Millipore